GB201708330D0 - Fusion protein for enhancing intestinal regeneration - Google Patents

Fusion protein for enhancing intestinal regeneration

Info

Publication number
GB201708330D0
GB201708330D0 GBGB1708330.4A GB201708330A GB201708330D0 GB 201708330 D0 GB201708330 D0 GB 201708330D0 GB 201708330 A GB201708330 A GB 201708330A GB 201708330 D0 GB201708330 D0 GB 201708330D0
Authority
GB
United Kingdom
Prior art keywords
fusion protein
enhancing intestinal
intestinal regeneration
regeneration
enhancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1708330.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Nederlandse Akademie van Wetenschappen
Original Assignee
Koninklijke Nederlandse Akademie van Wetenschappen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Nederlandse Akademie van Wetenschappen filed Critical Koninklijke Nederlandse Akademie van Wetenschappen
Priority to GBGB1708330.4A priority Critical patent/GB201708330D0/en
Publication of GB201708330D0 publication Critical patent/GB201708330D0/en
Priority to PCT/EP2018/063708 priority patent/WO2018215614A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1708330.4A 2017-05-24 2017-05-24 Fusion protein for enhancing intestinal regeneration Ceased GB201708330D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1708330.4A GB201708330D0 (en) 2017-05-24 2017-05-24 Fusion protein for enhancing intestinal regeneration
PCT/EP2018/063708 WO2018215614A1 (en) 2017-05-24 2018-05-24 Fusion protein for enhancing intestinal regeneration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1708330.4A GB201708330D0 (en) 2017-05-24 2017-05-24 Fusion protein for enhancing intestinal regeneration

Publications (1)

Publication Number Publication Date
GB201708330D0 true GB201708330D0 (en) 2017-07-05

Family

ID=59220776

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1708330.4A Ceased GB201708330D0 (en) 2017-05-24 2017-05-24 Fusion protein for enhancing intestinal regeneration

Country Status (2)

Country Link
GB (1) GB201708330D0 (en)
WO (1) WO2018215614A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3050133A1 (en) 2017-01-26 2018-08-02 Surrozen, Inc. Tissue-specific wnt signal enhancing molecules and uses thereof
GB202105212D0 (en) * 2021-04-12 2021-05-26 Acad Medisch Ct WNT agonists for prevention of cancer
CN113234681B (en) * 2021-06-16 2022-07-19 北京中医药大学 Method for establishing stomach precancerous state organoid model and special culture medium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201106395D0 (en) * 2011-04-14 2011-06-01 Hubrecht Inst Compounds

Also Published As

Publication number Publication date
WO2018215614A1 (en) 2018-11-29

Similar Documents

Publication Publication Date Title
HK1244019A1 (en) Fusion proteins
ZA201701810B (en) Sirp-alpha immunoglobulin fusion proteins
GB201509413D0 (en) Fusion protein
HK1247933A1 (en) Fusion protein containing bdnf
IL254883A0 (en) Method for protein purification
GB201504691D0 (en) Fusion protein
GB201711481D0 (en) Protein purification
ZA202003845B (en) Fusion proteins
SG11202101904UA (en) Spd-1 variant - fc fusion proteins
IL272807A (en) Method for purifying proteins
GB201800334D0 (en) Modified protein
IL273626A (en) Immunomodulatory fusion proteins
HK1257937A1 (en) Fusion protein
GB201708330D0 (en) Fusion protein for enhancing intestinal regeneration
ZA202102533B (en) Fusion protein
SG11201606501PA (en) Nanobody-fluorescent protein fusion
GB201602850D0 (en) Fusion proteins
EP3649159C0 (en) Fusion protein
HK1257713A1 (en) Method for protein purification
GB201712792D0 (en) Fusion protein
GB201703416D0 (en) Method for protein expression
IL244857A0 (en) Acetylcholinesterase-fc domain fusion protein
GB201603763D0 (en) Method for protein expression

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)